An in vivo microdialysis coupled with liquid chromatography/tandem mass spectrometry study of cortisol metabolism in monkey adipose tissue

Analytical Biochemistry

Volumn 381, Issue 2, 2008, Pages 214-223

  Sun, Li ^a   Stenken, Julie A ^b   Brunner, Janice E ^a   Michel, Kimberly B ^a   Adelsberger, Jennifer K ^a   Yang, Amy Y ^a   Zhao, Jamie J ^a   Musson, Donald G ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF ARKANSAS   (United States)

Author keywords

11 HSD1; Adipose tissue; Analysis; Cortisol; Cortisone; Enzyme; LC MS MS; Metabolism; Microdialysis; Stable isotope labeled

Indexed keywords

CORTISOL; DEHYDROGENATION; DIALYSIS; ENZYMES; HISTOLOGY; ISOTOPES; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; METABOLISM;

ADIPOSE TISSUE; ANALYSIS; CORTISONE; LC/MS/MS; MICRO-DIALYSIS; STABLE ISOTOPES;

TISSUE;

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1B; CORTISONE; HYDROCORTISONE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; EXTRACTION; FEMALE; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SENSITIVITY AND SPECIFICITY; STEROID METABOLISM; TANDEM MASS SPECTROMETRY;

MACACA MULATTA; MAMMALIA;

EID: 50249143428     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2008.06.036     Document Type: Article

References (43)

1. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
2. Wake D.J., Rask E., Livingstone D.E.W., Soderberg S., Olsson T., and Walker B.R. Local and systemic impact of transcriptional up-regulation of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J. Clin. Endocrinol. Metab. 88 (2003) 3983-3988
3. Stulnig T.M., and Waldhausl W. 11β-Hydroxysteroid dehydrogenase type 1 in obesity and type 2 diabetes. Diabetologia 47 (2004) 1-11
4. Lindsay R.S., Wake D.J., Nair S., Bunt J., Livingstone D.E.W., Permana P.A., Tataranni P.A., and Walker B.R. Subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 88 (2003) 2738-2744
5. Bujalska I., Shimojo M., Howie A., and Stewart P.M. Human 11β-hydroxysteroid dehydrogenase: Studies on stably transfected isoforms and localization of the type 2 isozeme within renal tissue. Steroids 62 (1997) 77-82
6. Quinkler M., Kosmale B., Bähr V., Oelkers W., and Diederich S. Evidence for isoforms of 11β-hydroxysteroid dehydrogenases in the liver and kidney of the guinea pig. J. Endocrinol. 153 (1997) 291-298
7. Schipper L., Spee B., Rothuizen J., Nijnanten F.W., and Fink-Gremmels J. Characterization of 11β-hydroxysteroid dehydrogenases in feline kidney and liver. Biochim. Biophys. Acta 1688 (2004) 68-77
8. Seckl J.R., and Walker B.R. Minireview: 11β-Hydroxysteroid dehydrogenase type 1-a tissue-specific amplifier of glucocorticoid action. Endocrinology 142 (2001) 1371-1376
9. Putignano P., Giraldi F.P., and Cavagnini F. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenases type 1 and pathogenesis of the metabolic syndrome. J. Endocrinol. Invest. 27 (2004) 969-974
10. Best R., and Walker B.R. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolisms in assessing the activity of 11β-hydroxysteroid dehydrogenase in vivo. Clin. Endocrinol. 47 (1997) 231-236
11. Andrew R., Smith K., Jones G.C., and Walker B.R. Distinguishing the activities of 11β-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J. Clin. Endocrinol. Metab. 87 (2002) 277-285
12. Chrousos G.P., Charmandari E., and Kino T. Glucocorticoid action networks-an introduction to system biology. J. Clin. Endocrinol. Metab. 89 (2004) 563-564
13. Chrousos G.P. Is 11β-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?. Proc. Natl. Acad. Sci. USA 101 (2004) 6329-6330
14. Abel S.M., Back D.J., Maggs J.L., and Park B.K. Cortisol metabolism by human liver in vitro-I. Metabolite identification and inter-individual variability. J. Steroid Biochem. Mol. Biol. 43 (1992) 713-719
15. Sandeep T.C., Yau J., MacLullich A., Noble J., Deary I.J., Walker B.R., and Seckl J.R. 11β-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc. Natl. Acad. Sci. USA 101 (2004) 6734-6739
16. Katz J.R., Mohamed-Ali V., Wood P.J., Yudkin J.S., and Coppack S.W. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin. Endocrinol. 50 (1999) 63-68
17. Scott D.O., and Lunte C.E. In vivo microdialysis sampling in the bile, blood and liver of rats to study the disposition of phenol. Pharm. Res. 10 (1993) 335-342
18. Belle K.V., Sarre S., Ebinger G., and Michotte Y. Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clamipramine in rats: a quantitative microdialysis study. J. Pharmacol. Exp. Ther. 272 (1995) 1217-1222
19. Freed A.L., Cooper J.D., Davies M.I., and Lunte S.M. Investigation of the metabolism of substance P in rat striatum by microdialysis sampling and capillary electrophoresis with laser-induced fluorescence detection. J. Neurosci. Methods 109 (2001) 23-29
20. Kajiro T., Nakajima Y., Fukushima T., and Imai K. A method to evaluate the rennin-angiotensin system in rat renal cortex using a microdialysis technique combined with HPLC-Fluorescence detection. Anal. Chem. 74 (2002) 4519-4525
21. Venero C., and Borrell J. Rapid glucocorticoid effects on excitatory amino acid levels in the hippocampus: a microdialysis study in freely moving rats. Eur. J. Neurosci. 11 (1999) 2465-2473
22. Cook C.J. Measuring of extracellular cortisol and corticotrophin-releasing hormone in the amygdale using immunosensor coupled microdialysis. J. Neurosci. Methods 110 (2001) 95-101
23. Tomlinson J.W., Sherlock M., Hughes B., Hughes S.V., Kilvington F., Bartlett W., Courtney R., Rejto P., Carley W., and Stewart P. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. J. Clin. Endocrinol. Metab. 92 (2007) 857-864
24. Sandeep T.C., Andrew R., Homer N.Z.M., Andrews R.C., Smith K., and Walker B.R. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and the effects of 11β-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54 (2005) 872-879
25. Wake D.J., M Homer N.Z., Andrew R., and Walker B.R. Acute in vivo regulation of 11β-hedroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J. Clin. Endocrinol. Metab. 91 (2006) 4682-4688
26. Lanckmans K., Sarre S., Smolders I., and Michotte Y. Use of a structural analogue versus a stable isotope labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano-liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 21 (2007) 1187-1195
27. Lin S.N., Slopis J.M., Butler I.J., and Caprioli R.M. In vivo microdialysis and gas chromatography/mass spectrometry for studies on release of N-acetylaspartlyglutamate and N-acetylaspartate in rat brain hypothalamus. J. Neurosci. Methods 62 (1995) 199-205
28. Lanckmans K., Sarre S., Smolders I., and Michotte Y. Quantitative liquid chromatography/mass spectrometry for the analysis of microdialysates. Talanta 74 (2008) 458-469
29. Shibasaki H., Furuta T., and Kasuya Y. Simultaneous determination of cortisol and cortisone in human plasma by stable-isotope dilution mass spectrometry. J. Chromatogr. 576 (1992) 47-52
30. Sun L., Stenken J.A., Yang A.Y., Zhao J.J., and Musson D.G. An in vitro microdialysis methodology to study 11β-hydroxysteroid dehydrogenase type 1 enzyme activity in liver microsomes. Anal. Biochem. 370 (2007) 26-37
31. Bungay P.M., Morrison P.F., and Dedrick R.L. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci. 46 (1990) 105-119
32. Moore C.C.D., Mellon S.H., Murai J., Siiteri P.K., and Miller W.L. Structure and function of the hepatic form of 11β-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance. Endocrinology 133 (1993) 368-375
33. Hansen D.K., Davies M.I., Lunte S.M., and Lunte C.E. Pharmacokinetic and metabolism studies using microdialysis sampling. J. Pharm. Sci. 88 (1999) 14-27
34. Stenken J.A. Methods and issues in microdialysis calibration. Anal. Chim. Acta 379 (1999) 337-358
35. Muller M., Schmid R., Georgopoulos A., Buxbaum A., Wasicek C., and Eichler H.G. Application of microdialysis to clinical pharmacokinetics in humans. Clin. Pharmacol. Ther. 57 (1995) 371-380
36. Stenken J.A., Stahle L., Lunte C.E., and Southard M.Z. Monitoring in situ liver metabolism in rats using microdialysis. Comparison of microdialysis mass-transport model predictions to experimental metabolite generation data. J. Pharm. Sci. 87 (1998) 311-320
37. Stenken J.A., Holunga D.M., Decker S.A., and Sun L. Experimental and theoretical microdialysis studies of in situ metabolism. Anal. Biochem. 290 (2001) 314-323
38. Hult M., Jornvall H., and Oppermann U.C.T. Selective inhibition of human type 1 11β-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics. FEBS Lett. 441 (1998) 25-28
39. Ricketts M.L., Shoesmith K.J., Hewison M., Strain A., Eggo M.C., and Stewart P.M. Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. J. Endocrinol. 156 (1998) 159-168
40. Shafqat N., Elleby B., Svensson S., Shafquat J., Jornvall H., Abrahmsen L., and Oppermann U. Comparative enzymology of 11β-hydroxysteroid dehydrogenase type 1 from glucocorticoid resistant (Guinea pig) versus sensitive (Human) species. J. Biol. Chem. 278 (2003) 2030-2035
41. Kasuya Y., Yokokawa A., Takayama S., Shibasaki H., and Furuta T. Evaluation of 11β-HSD activities in vivo following oral administration of cortisol-13C4,2H1 to a human subject. Steroids 68 (2003) 167-176
42. Kasuya Y., Yokokawa A., Shibasaki H., and Furuta T. Measurement of cortisol secretion rate by stable isotope methodology following oral administration of 13 C-labeled cortisol to a human subject. Steroids 67 (2002) 783-788
43. Holaday J.W., Meyerhoff J.L., and Natelson B.H. Cortisol secretion and clearance in the rhesus monkey. Endocrinology 100 (1977) 1178-1185